|
- 2019
Safety and efficacy of combination therapy with apatinib and doxorubicin in metastatic soft tissue sarcomas: an observational study from multiple institutionsDOI: 10.2147/CMAR.S207150 Keywords: chemotherapy, apatinib, tyrosine-kinase inhibitor, sarcoma, adverse events Abstract: Purpose: Apatinib has shown effectiveness in treating sarcoma. This study aimed to assess the safety and efficacy of apatinib and doxorubicin combination therapy in metastatic soft tissue sarcomas (STS) and to compare the therapeutic effects of two treatments (apatinib after doxorubicin vs apatinib plus doxorubicin) on STS
|